论文部分内容阅读
一项与国际接轨、用于检测中药化学成分的“指纹图潜”技术日前在浙江大学制药工程研究所取得重要进展,并有望在中药注射剂领域率先实现突破,为长期因有效成分不清而受困扰的中药办上“身份证”。 中药是我国具有自主知识产权、少数几个比较具有国际优势的产业之一。然而,由于化学成分复杂,质量检测和分析困难,中药长期缺乏科学规范的标准和质量控制手段,出口严重受阻,在国际中药市场的份额不足5％,中药产业与中药大国的地位极不相称。
A “fingerprint latent” technology that is in line with international standards to detect the chemical composition of Chinese medicine has made important progress in the Institute of Pharmaceutical Engineering of Zhejiang University. It is expected that it will be the first breakthrough in the field of traditional Chinese medicine injections and will be subject to long-term unclear active ingredients. The troubled Chinese medicine is running on “ID cards.” Traditional Chinese medicine is one of the few industries in our country that have independent intellectual property rights and have comparatively international advantages. However, due to the complexity of chemical composition and difficulties in quality detection and analysis, Chinese medicine has long lacked scientific and standardized standards and quality control measures, and its export has been severely hampered. Its share in the international Chinese medicine market is less than 5%. The Chinese medicine industry is not commensurate with the status of major Chinese medicine countries.